about
Regulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated ratsAutophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine.Large graphene quantum dots alleviate immune-mediated liver damage.Coordinated activation of AMP-activated protein kinase, extracellular signal-regulated kinase, and autophagy regulates phorbol myristate acetate-induced differentiation of SH-SY5Y neuroblastoma cells.In vitro and in vivo anti-melanoma action of metformin.Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway.Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60).AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C.Synergistic antiglioma action of hyperthermia and nitric oxide.Modulation of tumor necrosis factor-mediated cell death by fullerenes.Metformin aggravates immune-mediated liver injury in mice.Oxidative stress-mediated hemolytic activity of solvent exchange-prepared fullerene (C60) nanoparticles.The protection of cells from nitric oxide-mediated apoptotic death by mechanochemically synthesized fullerene (C(60)) nanoparticles.The mechanism of cell-damaging reactive oxygen generation by colloidal fullerenes.Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake.Effects of Intracerebroventricularly (ICV) Injected Ghrelin on Cardiac Inducible Nitric Oxide Synthase Activity/Expression in Obese Rats.Mechanisms and therapeutic significance of autophagy modulation by antipsychotic drugs
P50
Q28575518-C52A43D3-B955-4465-90A6-F48FF1D6154AQ35852767-523DB41C-0F87-4D1F-87D8-25FE3F01BC91Q38938654-6A5D67B4-94DE-498C-9D3D-C4B519FE323CQ38944849-509BE4D1-AF51-4588-BC8D-C7188F47026BQ39497029-E5AA479B-934A-4DBD-A1FE-F8171CD1B68BQ39639032-C06FF61E-A7F7-4E77-A173-E9C6DAF25FB1Q39712439-12F820CC-E70E-4B96-9825-7A071001E023Q39795145-6511ABE3-C0C3-45DA-8FAE-2F3A9BE38D32Q39854291-10964F78-B72B-4197-86D3-22A0BE4F8F92Q40014870-084E16BC-8CE3-442D-8F31-3D95AC7DE901Q40052726-138EEA7B-FA65-44B2-866C-52577DACE0CAQ41921624-AD0E1B31-A756-4B00-8055-2CE01C288940Q42931805-1315091F-52FA-40A0-8170-DBC5CF7E43CBQ46132265-1976DAEE-F82B-46AE-BEAF-1FF4CA9A5227Q46990006-7EA761AF-60C9-4E6A-8D32-7DEFEC004370Q48655114-C085A43D-1E6E-4712-AAB1-8ADD93F33179Q53266389-058BDBE8-ECC0-4F1E-B871-BFABFE63B9CAQ92932105-9D0F93E9-1523-4D3D-8C82-31AB7A6E6472
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maja Misirkic
@en
Maja Misirkic
@nl
type
label
Maja Misirkic
@en
Maja Misirkic
@nl
prefLabel
Maja Misirkic
@en
Maja Misirkic
@nl
P31
P496
0000-0002-0510-826X